Odyssey Therapeutics Inc (ODTX)

Finanzdaten der Odyssey Therapeutics Inc-Aktie (ODTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
Revenues	-	-
	39.44%55.47	39.78
Research and Development	12.08%36.23	32.32
Operating Income/Loss	39.44%-55.47	-39.78
Nonoperating Income/Loss	69.13%2.67	1.58
Income/Loss From Continuing Operations Before Tax	38.21%-52.80	-38.20
Income Tax Expense/Benefit	112.70%-0.01	0.06
	37.96%-52.79	-38.26
Attributable To Parent	37.96%-52.79	-38.26
Available To Common Stockholders, Basic	37.96%-52.79	-38.26
Basic Average Shares	435.34%30.28	5.66
Diluted Average Shares	435.34%30.28	5.66
Basic Earnings Per Share	74.30%-1.74	-6.77
Diluted Earnings Per Share	74.30%-1.74	-6.77